Variant report
Variant | nsv569445 |
---|---|
Chromosome Location | chr15:53974567-53985450 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:28)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:28 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | FOXA2 | chr15:53976442-53977238 | A549 | lung: | n/a | n/a |
2 | FOXA2 | chr15:53976578-53977127 | A549 | lung: | n/a | n/a |
3 | MYC | chr15:53976527-53976589 | MCF-7 | breast: | n/a | n/a |
4 | POLR2A | chr15:53976365-53976543 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | POLR2A | chr15:53976466-53976847 | H1-hESC | embryonic stem cell: | n/a | n/a |
6 | POLR2A | chr15:53976371-53976606 | A549 | lung: | n/a | n/a |
7 | POLR2A | chr15:53976439-53976578 | MCF-7 | breast: | n/a | n/a |
8 | POLR2A | chr15:53983285-53983385 | A549 | lung: | n/a | n/a |
9 | POLR2A | chr15:53977143-53977156 | A549 | lung: | n/a | n/a |
10 | POLR2A | chr15:53976502-53976560 | A549 | lung: | n/a | n/a |
11 | POLR2A | chr15:53977060-53977117 | A549 | lung: | n/a | n/a |
12 | POLR2A | chr15:53976380-53976392 | MCF-7 | breast: | n/a | n/a |
13 | POLR2A | chr15:53977137-53977141 | A549 | lung: | n/a | n/a |
14 | POLR2A | chr15:53976416-53976431 | MCF-7 | breast: | n/a | n/a |
15 | POLR2A | chr15:53976900-53977056 | H1-hESC | embryonic stem cell: | n/a | n/a |
16 | POLR2A | chr15:53976892-53977119 | H1-hESC | embryonic stem cell: | n/a | n/a |
17 | REST | chr15:53976884-53977021 | H1-hESC | embryonic stem cell: | n/a | n/a |
18 | REST | chr15:53980751-53980894 | H1-hESC | embryonic stem cell: | n/a | n/a |
19 | RXRA | chr15:53976876-53977076 | HepG2 | liver: | n/a | n/a |
20 | SETDB1 | chr15:53975007-53975789 | U2OS | brain: | n/a | n/a |
21 | SP1 | chr15:53980725-53980909 | HepG2 | liver: | n/a | n/a |
22 | SP1 | chr15:53976855-53977119 | HepG2 | liver: | n/a | n/a |
23 | STAT3 | chr15:53985100-53985299 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | TAF1 | chr15:53976337-53976685 | H1-hESC | embryonic stem cell: | n/a | n/a |
25 | YY1 | chr15:53976292-53976463 | HCT-116 | colon: | n/a | n/a |
26 | YY1 | chr15:53976204-53976796 | A549 | lung: | n/a | n/a |
27 | YY1 | chr15:53976208-53976475 | A549 | lung: | n/a | n/a |
28 | ZBTB33 | chr15:53976864-53977110 | HepG2 | liver: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr15:53984291..53986517-chr15:53987767..53990202,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
WDR72 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs528829869 | chr15:53974573-53974574 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs368569719 | chr15:53974581-53974582 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs78049578 | chr15:53974601-53974602 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs569578743 | chr15:53974621-53974622 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs532245146 | chr15:53974625-53974626 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs552068044 | chr15:53974643-53974644 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs143804888 | chr15:53974648-53974649 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs7180008 | chr15:53974673-53974674 | Weak transcription Strong transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs201461548 | chr15:53974712-53974713 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs568529889 | chr15:53974727-53974728 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs192690183 | chr15:53974736-53974737 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs557297151 | chr15:53974784-53974785 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs60122973 | chr15:53974836-53974837 | Weak transcription Strong transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs546480572 | chr15:53974861-53974862 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs114482244 | chr15:53974872-53974873 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs58604383 | chr15:53974882-53974883 | Weak transcription Strong transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs2126187 | chr15:53974893-53974894 | Weak transcription Strong transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs35811952 | chr15:53974933-53974934 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs562177798 | chr15:53974967-53974968 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs574452289 | chr15:53974972-53974973 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs543173868 | chr15:53974973-53974974 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs151099048 | chr15:53974990-53974991 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs80059366 | chr15:53974992-53974993 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs556513649 | chr15:53975008-53975009 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs552004614 | chr15:53975025-53975026 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs141345200 | chr15:53975053-53975054 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs2447053 | chr15:53975084-53975085 | Weak transcription Strong transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs548345556 | chr15:53975186-53975187 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs78991149 | chr15:53975192-53975193 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs184984855 | chr15:53975219-53975220 | Weak transcription Strong transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs550807885 | chr15:53975222-53975223 | Weak transcription Strong transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs79059634 | chr15:53975240-53975241 | Weak transcription Strong transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs539840320 | chr15:53975276-53975277 | Weak transcription Strong transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs140126618 | chr15:53975287-53975288 | Weak transcription Strong transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs553020683 | chr15:53975292-53975293 | Weak transcription Strong transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs116353246 | chr15:53975297-53975298 | Weak transcription Strong transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs573562693 | chr15:53975316-53975317 | Weak transcription Strong transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs535799868 | chr15:53975370-53975371 | Weak transcription Strong transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs74015881 | chr15:53975388-53975389 | Weak transcription Strong transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs12437464 | chr15:53975404-53975405 | Weak transcription Strong transcription Active TSS Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs138845545 | chr15:53975408-53975409 | Weak transcription Strong transcription Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs76983488 | chr15:53975420-53975421 | Weak transcription Strong transcription Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs186550603 | chr15:53975433-53975434 | Weak transcription Strong transcription Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs576575475 | chr15:53975435-53975436 | Weak transcription Strong transcription Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs28470509 | chr15:53975439-53975440 | Weak transcription Strong transcription Active TSS Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs115661868 | chr15:53975451-53975452 | Weak transcription Strong transcription Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs377288261 | chr15:53975464-53975465 | Weak transcription Strong transcription Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs191378697 | chr15:53975465-53975466 | Weak transcription Strong transcription Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs141972968 | chr15:53975501-53975502 | Weak transcription Strong transcription Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs112047025 | chr15:53975518-53975519 | Weak transcription Strong transcription Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Schizophrenia | 19415332 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
cataract | 16735990 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 21979893 | CNVD |
spastic paraplegia with thinning of corpus callosum | 19105190 | CNVD |
Schizophrenia | 21324950 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Disease | 21824424 | CNVD |
Melanoma | 18172304 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Gastric cancer | 17167181 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Intellectual disability | 22102821 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Breast cancer | 22032731 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Cancer | 21129771 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr15:53959600-53986200 | Weak transcription | Pancreas | Pancrea |
2 | chr15:53973600-53983200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr15:53974000-53975600 | Strong transcription | Liver | Liver |
4 | chr15:53974400-53975200 | Enhancers | A549 | lung |
5 | chr15:53975200-53975600 | Flanking Active TSS | A549 | lung |
6 | chr15:53975400-53976600 | Active TSS | Duodenum Mucosa | Duodenum |
7 | chr15:53975600-53976600 | Active TSS | A549 | lung |
8 | chr15:53975600-53982600 | Weak transcription | Liver | Liver |
9 | chr15:53976000-53977200 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
10 | chr15:53976200-53976600 | Active TSS | ES-WA7 Cell Line | embryonic stem cell |
11 | chr15:53976400-53977000 | Active TSS | H9 Cell Line | embryonic stem cell |
12 | chr15:53976400-53977000 | Active TSS | HUES6 Cell Line | embryonic stem cell |
13 | chr15:53976600-53990600 | Weak transcription | A549 | lung |
14 | chr15:53976800-53977200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
15 | chr15:53977000-53977200 | Flanking Active TSS | H9 Cell Line | embryonic stem cell |
16 | chr15:53977000-53977200 | Flanking Active TSS | HUES6 Cell Line | embryonic stem cell |
17 | chr15:53982600-53985000 | Strong transcription | Liver | Liver |
18 | chr15:53983200-53983600 | ZNF genes & repeats | H1 Derived Mesenchymal Stem Cells | ES cell derived |
19 | chr15:53983600-53986400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
20 | chr15:53984200-53988600 | Enhancers | Fetal Heart | heart |
21 | chr15:53985000-53986000 | Weak transcription | Liver | Liver |